Historical record - last NADAC effective date: 6/19/2024
Product Information
SEVELAMER 0.8 GM POWDER PACKET is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $1.7318 per EA under NDC 00955105290. Its NADAC has been published 145 times since Jan 20, 2021.
FDA first approved this application on Feb 18, 2009.
Strength
.8 g/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00955105290
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
SEVELAMER CARBONATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022318FDA Approved
2/18/2009
On Market Since
1/1/2018
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER 0.8 GM POWDER PACKET has been published 145 times since Jan 20, 2021, and over the history we have for it it has declined 74.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7318 per EA |
|---|---|
| All-time high | $6.8121 (Jan 12, 2022) |
| All-time low | $1.6907 (May 22, 2024) |
| Median price | $3.1007 |
| Average price | $4.2569 |
| Largest weekly change | -54.5% (Sep 21, 2022) |
| Weeks tracked | 145 |
| Tracking since | Jan 20, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-36.2%
5Y
-74.6%
All
-74.6%
Last surveyed Jun 26, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sevelamer Carbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sanofi-Aventis U.S. LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sevelamer Carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SEVELAMER 0.8 GM POWDER PACKET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER 0.8 GM POWDER PACKET, manufactured by Sanofi-Aventis U.S. LLC, is $1.7318 per EA (NDC 00955105290), effective Jun 26, 2024.
How has the price of SEVELAMER 0.8 GM POWDER PACKET changed over time?
Over the history we have for it, the NADAC for SEVELAMER 0.8 GM POWDER PACKET has declined 74.6%. It has been tracked across 145 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for SEVELAMER 0.8 GM POWDER PACKET?
Since Jan 20, 2021, the NADAC for SEVELAMER 0.8 GM POWDER PACKET has ranged from a low of $1.6907 (May 22, 2024) to a high of $6.8121 (Jan 12, 2022), with a median of $3.1007 per EA.
Are there cheaper alternatives to SEVELAMER 0.8 GM POWDER PACKET?
No other NADAC-published product currently shares the active ingredient and strength of SEVELAMER 0.8 GM POWDER PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SEVELAMER 0.8 GM POWDER PACKET?
SEVELAMER 0.8 GM POWDER PACKET (NDC 00955105290) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.